About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,704 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,704 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1061-1080 of 3,704 trials

UnknownEvaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis PatientsCognitive disorders are well-known in multiple sclerosis (MS), even in earlier stages of the disease. They effect personal life.NCT01659593·Nancy UnknownTCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple SclerosisIn the present study, we, the investigators at Sheba Medical Center, intend to evaluate T cell vaccination (TCV) in patients with probable multiple sclerosis (MS) within up to 3…NCT00228228·Ramat Gan CompletedFollow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)The purpose of this single visit extension study is to explore immune status in RRMS patients treated for at least 48 months with fingolimod.NCT02720107·Ostfildern, Baden-Wurttemberg and 25 others

Related Searches

Data from ClinicalTrials.govTerms

RecruitingClinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)This prospective cohort study is part of the Clinnova programme and aims to (i) identify clinical imaging and omics characteristics associated with early Multiple Sclerosis (MS)…NCT06526364·Basel

CompletedTreatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple SclerosisRandomized, placebo-controlled, crossover, 4-sequence, 4-period, double-blind (participants and investigators), multicenter trial of 3 commonly used medications for treatment of…NCT03185065·San Francisco, California and 1 other

UnknownThe Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple SclerosisPersonal identity is composed of multiple facets of the self that are constructed and nourished through memories of past experiences (i.e., autobiographical memory) and the…NCT05648292·Garches, Hauts De Seine

CompletedBiomarkers and Response to Natalizumab for Multiple Sclerosis TreatmentInformation from blood samples may help us for choosing the best treatment in future personalized medicine.NCT00942214·Toulouse

CompletedExamining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple SclerosisDance Dance Revolution (DDR) may offer an innovative and highly effective format for delivering exercise programs to people with multiple sclerosis (MS).NCT01780792·Columbus, Ohio

CompletedStudy of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) PatientsThe main purpose of this study was to assess the efficacy and safety of 0.5mg Fingolimod (Gilenya) in Chinese patients with relapsing multiple sclerosis (RMS)NCT04667949·Beijing, Beijing Municipality and 12 others

WithdrawnPhase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MSThe primary objective is to establish the safety of administration of intranasal Foralumab in non-active primary and secondary progressive Multiple Sclerosis (MS) patients in a…NCT05029609

CompletedNeuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation ProgrammeMultiple sclerosis (MS) is a central nervous system inflammatory disease that causes a chronic and progressive physical handicap.NCT03471338·Caen, Calvados

CompletedA Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.NCT00239993·Fullerton, California and 5 others

UnknownHigh Intensity Interval Gait Training in Multiple SclerosisOver 90% of persons with MS (pwMS) complain of difficulty with walking.NCT05529498·New York, New York

CompletedAlemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective PotentialAlemtuzumab is the active agent of a drug called Lemtrada®.NCT02419378·Münster

CompletedEnhance Wellness for Individuals With Long-Term Physical DisabilitiesThis project is an adaptation trial, testing the efficacy of an evidence-based community wellness program, Enhance Wellness (http://www.projectenhance.org/enhancewellness.aspx)…NCT02815878·Seattle, Washington

TerminatedA Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)PF-06342674 (RN168), being developed for the treatment of multiple sclerosis (MS), is an antibody that binds to and inhibits the human interleukin-7 receptor, a component…NCT02045732·Albany, New York and 7 others

CompletedPropionic Acid in Multiple SclerosisThe purpose of this study is to demonstrate the superiority of propionic acid over placebo as add on treatment in multiple sclerosis (MS).NCT06402487·Salzburg, State of Salzburg

CompletedTranscranial Doppler in Multiple SclerosisThe aim of this study is to investigate the potential of Transcranial doppler (TCD) and Near-Infrared Spectroscopy (NIRS), more simple and non-invasive bedside methods than…NCT02389426·Jette, Vlaams-Brabant

CompletedAcceptance Based Telephone Support When Transitioning to SPMSWhat is the purpose of the study?NCT04239664·Nottingham, Nottinghamshire

CompletedThe Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CISDisruption of the blood brain barrier (BBB) is associated with inflammatory conditions of the central nervous system (CNS).NCT03451955·Copenhagen, Frederiksberg and 1 other

PreviousPage 54 of 186Next